Sun Pharmaceuticals Industries (BOM:524715) 3-Year EPS without NRI Growth Rate : 30.30% (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Sun Pharmaceuticals Industries 3-Year EPS without NRI Growth Rate?

Sun Pharmaceuticals Industries's EPS without NRI for the three months ended in Dec. 2023 was ₹10.75.

During the past 12 months, Sun Pharmaceuticals Industries's average EPS without NRI Growth Rate was 35.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was 30.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 26.70% per year. During the past 10 years, the average EPS without NRI Growth Rate was 3.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Sun Pharmaceuticals Industries was 51.10% per year. The lowest was -17.90% per year. And the median was 18.70% per year.

Competitive Comparison of Sun Pharmaceuticals Industries's 3-Year EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharmaceuticals Industries's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sun Pharmaceuticals Industries's 3-Year EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharmaceuticals Industries's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Sun Pharmaceuticals Industries's 3-Year EPS without NRI Growth Rate falls into.

Sun Pharmaceuticals Industries 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

Sun Pharmaceuticals Industries (BOM:524715) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Sun Pharmaceuticals Industries 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Sun Pharmaceuticals Industries's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Pharmaceuticals Industries (BOM:524715) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (BOM:524715) » Definitions » 3-Year EPS without NRI Growth Rate

Traded in Other Exchanges

SUNPHARMA:India

Address

Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063

Website

https://www.sunpharma.com

Sun Pharmaceuticals Industries Ltd is India's largest generic pharmaceutical manufacturer and the fourth largest in the world. The company's largest markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is primarily based in India.

Sun Pharmaceuticals Industries (BOM:524715) Headlines

No Headlines